Skip to content
Open access

Perioperative Safety and Long‐Term Oncological Outcomes of En Bloc Resection of Bladder Tumor: A Multicenter Real‐World Study of 668 Patients

Sep 2026 · International journal of urology · Vol 33 · 0 citations · 22 references
Medicine

Abstract

To evaluate perioperative safety, pathological outcomes, and oncological outcomes of en bloc resection of bladder tumor (ERBT) in a large multicenter real‐world cohort.

Read PDF

Similar papers

Open access Aug 2026

Oncologic Outcomes in a Contemporary “PROTEUS-like” Cohort of High-risk Prostate Cancer Treated with Radical Prostatectomy Without Neoadjuvant Hormonal Therapy

Take Home Message In men meeting strict PROTEUS high-risk criteria, an upfront radical prostatectomy strategy was associated with substantial biochemical recurrence and metastatic progression. These contemporary outcomes provide a real-world benchmark for contextualizing forthcoming PROTEUS results and informing risk-a...

Can Aydogdu, Benso John, Clara Seizer et al. · 0 citations
Open access Sep 2026

Long‐term outcomes and patterns of failure in patients with thymic malignancies treated with surgery and radiation therapy

The role of peri‐operative radiation therapy in thymic epithelial tumors remains controversial, and randomized data are lacking. The authors evaluated recurrence patterns, pathologic predictors of recurrence, and long‐term survival among patients who underwent surgery and received peri‐operative radiation at a high‐vol...

O. Icht, I. Nardi-Agmon, P. Thavendiranathan et al. · 0 citations
Open access Sep 2026

‘Posterior (SMA‐first) Approach’ Versus ‘Standard Approach’ in Terms of Resection Margin and Long‐Term Survival After Pancreaticoduodenectomy for Periampullary and Pancreatic Carcinoma: A Randomized Trial

SMA‐first‐approach in pancreaticooduodenectomy (PD) was found to be associated with better oncological outcomes as compared to the standard approach both in our pilot study and a few retrospective studies. Hence, we performed a randomized controlled trial to compare these two approaches in terms of resection margins, l...

H. Jain, G. Sahota, A. Singh et al. · 0 citations
Aug 2026

Long‐Term Oncologic Outcomes of Neoadjuvant Tumor‐Directed Immunotherapy (PROSTVAC) Before Radical Prostatectomy for Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Trial

Biochemical recurrence (BCR) following radical prostatectomy (RP) occurs in 20%–40% of patients with localized prostate cancer. Neoadjuvant PROSTVAC has been shown to enhance T‐cell infiltration into the tumor immune microenvironment, but whether these immunologic changes translate into improved long‐term oncologic out...

B. Millan, Alexander P. Kenigsberg, Charles Hesswani et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.